Principales conclusions et analyse des parts de marché du vaccin contre la grippe H1N1 (grippe porcine) d'ici 2025-2031
H1N1 (Swine Flu) Vaccination Market Report Analysis
H1N1 (Swine Flu) Vaccination Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis AG
- Baxter International Inc.
- CSL Limited
- AstraZeneca plc.
- Zydus Cadila
- MedImmune
- GlaxoSmithKline plc.
- sanofi-aventis U.S. LLC
- GREEN CROSS CORP.
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Dispositif d'administration
- seringues
- injecteurs à jet
- autres dispositifs
By Voie d'administration
- vaccination intradermique
- vaccination intramusculaire
- vaccination sous-cutanée
By Utilisateur final
- hôpitaux
- centres chirurgicaux ambulatoires
- cliniques et centres de vaccination
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For